Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions

Cervical CancerHuman Papilloma Virus (HPV)

Trial Locations (1)

University of Florida, Gainesville

All Listed Sponsors

collaborator

Florida Department of Health

OTHER_GOV

lead

University of Florida

OTHER